title: [Assessment of the management of community-acquired pneumonia in adults outpatients].
abstract: BACKGROUND
  There is limited information about the effectiveness of the treatment of community-acquired pneumonia (CAP) in Chilean emergency rooms.
  
  
  OBJECTIVE
  To assess the treatment of CAP in emergency rooms at the Viña del Mar Health Service in Chile.
  
  
  METHODS
  Prospective study of immunocompetent adult patients consulting for a CAP in emergency rooms. Those that required hospital admission were considered ineligible. The initial clinical and laboratory assessment, antimicrobial treatment and their condition after 30 days of follow up, were recorded.
  
  
  RESULTS
  Three hundred eleven adult patients aged 57+/-22 years (152 males), were evaluated. Patients with class I CAP (40% of cases) were treated with Clarithromycin (71.8%) or Amoxicillin (26.6%) for 10 days. Patients with class II CAP (60%) were treated with Amoxicillin-clavulanate (80.7%) or Levofloxacin (18.2%) for 10 days. Three hundred eight patients (99%) were cured without need of hospital admission; three patients (1%) were subsequently hospitalized because of clinical failure of ambulatory treatment. Overall, three patients (1%) died; all deaths occurred during or immediately after hospitalization and were related to the severity of lung infection but not to the choice of antibiotic treatment.
  
  
  CONCLUSIONS
  The outpatient management of CAP by general practitioners working at emergency rooms was clinically effective with low rates of hospital admission and mortality.
authors.affiliation: Servicio de Medicina, Hospital de Quillota, Santiago de Chile.
authors.forename: Juana
authors.initials: J
authors.lastname: Pavié G
authors.forename: Julio Manuel de la
authors.initials: JM
authors.lastname: Prida C
authors.forename: Alejandro
authors.initials: A
authors.lastname: Díaz F
authors.forename: Fernando
authors.initials: F
authors.lastname: Saldías P
mesh_terms: D000293:Adolescent; D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D000553:Ambulatory Care; D000658:Amoxicillin / Q000627:therapeutic use; D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D016009:Chi-Square Distribution; D017291:Clarithromycin / Q000627:therapeutic use; D017714:Community-Acquired Infections / Q000188:drug therapy / Q000453:epidemiology; D004630:Emergencies; D005260:Female; D016330:Frail Elderly; D006801:Humans; D064704:Levofloxacin; D008297:Male; D008875:Middle Aged; D015242:Ofloxacin / Q000627:therapeutic use; D011014:Pneumonia / Q000188:drug therapy* / Q000453:epidemiology; D011446:Prospective Studies; D017211:Treatment Failure
chemical_list: D000900:Anti-Bacterial Agents; D064704:Levofloxacin; D000658:Amoxicillin; D015242:Ofloxacin; D017291:Clarithromycin